Seismic Therapeutic to Participate in Upcoming Investor Conferences

WATERTOWN, Mass.--(BUSINESS WIRE)-- Seismic Therapeutic, Inc., the machine learning immunology company, today announced that company management will participate in the following investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Thursday, September 5, 2024
Location: New York, NY
Format: Company presentation and 1x1 meetings

Cantor Global Healthcare Conference
Date: Tuesday, September 17, 2024
Location: New York, NY
Format: 1x1 meetings

Stifel 2024 Virtual Immunology and Inflammation Summit
Date: Wednesday, September 18, 2024
Location: Virtual
Format: Company presentation and 1x1 meetings

10th Annual World Medical Innovation Forum
Date: Wednesday, September 25, 2024
Location: Boston, MA
Format: Jo Viney, Ph.D., CEO, will be speaker at the panel presentation titled, “The Disruptors: The Role of Pathway Inhibition in Inflammation and Inflammatory Diseases”

BofA Healthcare Trailblazers Private Company Conference
Date: Wednesday, September 25, 2024
Location: Boston, MA
Format: 1x1 meetings

2024 RBC Capital Markets Biotechnology Private Company Virtual Conference
Date: Tuesday, October 1, 2024
Location: Virtual
Format: Company presentation and 1x1 meetings

Leerink Partners Biopharma Private Company Connect
Date: Wednesday, October 23, 2024
Location: Virtual
Format: 1x1 meetings

About Seismic Therapeutic
Seismic Therapeutic™ is a biotechnology company making a major shift in how immunology therapies are discovered and developed, enabled by machine learning. The company has a growing preclinical stage best-in-class and first-in-class biologics pipeline, derived from its integrated IMPACT platform, to control dysregulated adaptive immunity and address multiple autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com and follow us on LinkedIn and on X @Seismic_Tx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240826468972/en/

Media
Kathryn Morris, The Yates Network
914-204-6412
[email protected]

Investors
Emiley Demick, Precision AQ
212-362-1200
[email protected]

Source: Seismic Therapeutic, Inc.

You May Also Be Interested In

• WeBox Reaches $40 Million Annualized Sales Run Rate as Workplace Commerce Platform Expands Across Bay Area
• Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program
• PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities